Flexible and customized studies

Derisking therapeutic drug development

Cynbiose performs “derisking” studies that provide a combination of data on the in vivo behaviour of the drug candidate through the association of toxicological, pharmacokinetic, pharmacodynamic, histological and safety pharmacology parameters on reduced animal cohorts.

This preliminary exploratory approach reduces the risks before engaging in more advanced development phases that involve a significant financial commitment.

Our teams work closely with sponsors to define the number of animals and the various parameters necessary to carry out these studies.